
Apyx Medical Corporation APYX
$ 3.67
-1.87%
Annual report 2025
added 03-10-2026
Apyx Medical Corporation DPO Ratio 2011-2026 | APYX
Annual DPO Ratio Apyx Medical Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.3 | 51.9 | 52.8 | 62.9 | 50.7 | 54 | 97.3 | 88.1 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 97.3 | 50.7 | 63.8 |
Quarterly DPO Ratio Apyx Medical Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60.9 | 55.3 | 59.6 | - | 42.9 | - | - | - | - | - | 45.7 | - | 63.3 | 69.5 | 55.4 | - | 70.6 | 62.8 | 62.3 | - | 61.9 | 62.6 | 89.5 | - | 97.5 | 113 | 85.3 | - | 113 | 113 | 116 | - | 196 | 30.4 | 35 | - | 29.3 | 31.9 | 28.9 | - | 24.1 | 26.8 | 36.5 | - | 29.1 | 28 | 32 | - | 27.3 | 25.4 | 24 | - | 19.4 | 16 | 21.9 | - | 27.1 | 26.1 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 196 | 16 | 55.3 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
61.8 | $ 2.24 | 0.9 % | $ 3.5 M | ||
|
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | ||
|
AdaptHealth Corp.
AHCO
|
43.9 | $ 10.47 | 0.19 % | $ 1.41 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | ||
|
Alphatec Holdings
ATEC
|
73.8 | $ 12.56 | -3.75 % | $ 1.88 B | ||
|
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
33.2 | $ 9.61 | -13.93 % | $ 272 M | ||
|
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | ||
|
Cognyte Software Ltd.
CGNT
|
81.1 | $ 8.37 | 0.12 % | $ 601 M | ||
|
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | ||
|
Butterfly Network
BFLY
|
51.3 | $ 3.95 | -7.49 % | $ 836 M | ||
|
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | ||
|
Cytosorbents Corporation
CTSO
|
125 | $ 0.65 | -4.41 % | $ 35.4 M | ||
|
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | ||
|
Boston Scientific Corporation
BSX
|
61.7 | $ 71.28 | 0.11 % | $ 106 B | ||
|
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.92 | -3.21 % | $ 146 M | ||
|
CONMED Corporation
CNMD
|
57.3 | $ 36.71 | -1.69 % | $ 1.14 B | ||
|
Establishment Labs Holdings
ESTA
|
248 | $ 65.5 | 0.75 % | $ 1.94 B | ||
|
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | ||
|
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | ||
|
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | ||
|
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | ||
|
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | ||
|
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
48.6 | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
16.6 | $ 18.44 | -0.05 % | $ 121 M | ||
|
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | ||
|
InMode Ltd.
INMD
|
72.7 | $ 13.45 | -1.47 % | $ 869 M | ||
|
Abbott Laboratories
ABT
|
79.7 | $ 108.49 | -2.04 % | $ 189 B | ||
|
IRIDEX Corporation
IRIX
|
50.7 | $ 1.33 | - | $ 21.5 M | ||
|
Delcath Systems
DCTH
|
56 | $ 9.38 | -3.7 % | $ 336 M | ||
|
Bio-Rad Laboratories
BIO
|
41 | $ 267.99 | -0.55 % | $ 7.56 B | ||
|
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 16.66 | -3.2 % | $ 391 M | ||
|
Helius Medical Technologies
HSDT
|
362 | $ 2.07 | -4.61 % | $ 1.26 M | ||
|
AxoGen
AXGN
|
34.4 | $ 30.94 | -5.53 % | $ 1.42 B | ||
|
Align Technology
ALGN
|
33.7 | $ 172.41 | -2.11 % | $ 12.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 8.9 | -2.2 % | $ 685 M | ||
|
Bruker Corporation
BRKR
|
46.4 | $ 34.03 | 0.86 % | $ 5.07 K | ||
|
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
49.2 | $ 0.41 | 5.24 % | $ 42.1 M | ||
|
IRadimed Corporation
IRMD
|
34.8 | $ 99.67 | -3.04 % | $ 1.27 B |